Literature DB >> 12905139

The epidemiology of burn wound infections: then and now.

C Glen Mayhall1.   

Abstract

Burn wound infections are a serious complication of thermal injury. Although pneumonia is now the most important infection in patients with burns, burn wound infection remains a serious complication unique to the burn recipient. The methods for managing thermal injury have evolved during the past 50 years. This evolution has been accompanied by changes in the etiology, epidemiology, and approach to prevention of burn wound infections. In the 1950s, 1960s, and 1970s and into the mid-1980s, burn wounds were treated by the exposure method, with application of topical antimicrobials to the burn wound surface and gradual debridement with immersion hydrotherapy. As early burn wound excision and wound closure became the focal point of burn wound management, accompanied by a change from immersion hydrotherapy to showering hydrotherapy, the rate of burn wound infection appeared to decrease. Few epidemiologic studies have been done since this change in the approach to management of thermal injury. There are few data on the epidemiology of burn wound infections from the era of early excision and closure. Data are needed on infection rates for excised and closed burn wounds, the etiologies of these infections, and the epidemiology and the prevention of such infections. Additional studies are needed on the indications for topical and antimicrobial prophylaxis and selective decontamination of the digestive tract.

Entities:  

Mesh:

Year:  2003        PMID: 12905139     DOI: 10.1086/376993

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  67 in total

1.  Clinical experience in using the water jet in burn wound debridement.

Authors:  J-Y Yang; J-Y Hwuang; S-S Chuang
Journal:  Ann Burns Fire Disasters       Date:  2007-06-30

2.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

3.  Topical Antimicrobials in Burn Care: Part 1-Topical Antiseptics.

Authors:  Janos Cambiaso-Daniel; Stafanos Boukovalas; Genevieve H Bitz; Ludwik K Branski; David N Herndon; Derek M Culnan
Journal:  Ann Plast Surg       Date:  2018-01-09       Impact factor: 1.539

4.  Is there really a survival benefit of SDD in burns?

Authors:  Philippe Eggimann; René L Chioléro; Wassim Raffoul; Pierre Voirol; Mette M Berger
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

5.  Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study.

Authors:  Enrique Cerdá; Ana Abella; Miguel A de la Cal; José A Lorente; Paloma García-Hierro; Hendrick K F van Saene; Inmaculada Alía; Ainhoa Aranguren
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

6.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 7.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

8.  Risk Factors for Healthcare-Associated Infections in Adult Burn Patients.

Authors:  Paula D Strassle; Felicia N Williams; David J Weber; Emily E Sickbert-Bennett; Anne M Lachiewicz; Sonia Napravnik; Samuel W Jones; Bruce A Cairns; David van Duin
Journal:  Infect Control Hosp Epidemiol       Date:  2017-10-30       Impact factor: 3.254

9.  Prevalence of beta lactamase producing species of pseudomonas and acinetobacter in pediatric burn patients.

Authors:  B Sobouti; N Khosravi; A Daneshvar; S Fallah; M Moradi; Y Ghavami
Journal:  Ann Burns Fire Disasters       Date:  2015-09-30

10.  A simple cost-saving measure: 2.5% mafenide acetate solution.

Authors:  Amir Ibrahim; Shawn Fagan; Tim Keaney; Karim A Sarhane; Derek A Hursey; Philip Chang; Rob Sheridan; Colleen Ryan; Ronald Tompkins; Jeremy Goverman
Journal:  J Burn Care Res       Date:  2014 Jul-Aug       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.